Although GSK was shown to be promising in tumor cells with a loss of function of p53, we tested and showed the efficacy of nano-encapsulated GSK in U87-MG that possesses a wildtype p53 to monitor the drug effects [27]. This evidence concerns the gene TP53 and neoplasm.